10th Anniversary Inflammation & Immune Diseases Drug Discovery & Development Summit

Venue: Hyatt Regency New Brunswick

Location: New Brunswick, New Jersey, United States

Event Date/Time: Mar 20, 2006 End Date/Time: Mar 21, 2006
Early Registration Date: Jan 20, 2006
Report as Spam

Description

Now reaching its milestone 10-year anniversary, the Strategic Research Institute once again brings to you the much heralded “10th Annual Inflammation & Immune Diseases Drug Discovery & Development Summit”, March 20-21, 2006 in New Brunswick, NJ. Over the course of its path to attaining its 10-year mark, this conference series has attracted over 1,200 industry participants from pharma, biotech, academia, investment firms, service companies- you name it. Trend-setting scientists from industry- large and small, gather at this prestigious event to study and share their many promising areas of new treatment approaches for RA, rheumatic diseases, and autoimmune disorders. The 2006 faculty, vis-à-vis new topics and data, has been carefully assembled for the 10th anniversary show in order to cater your research interests and to answer your research questions for the years to come. Welcome!

KEYNOTE PRESENTATIONS:

To B or not to B: Targeting of Activation Induced Cytidine Deaminase as a Novel B Cell Therapy for Autoimmune Disease and Arthritis

John Mountz, M.D., Ph.D.
Professor, Department of Medicine Division of Clinical Immunology & Rheumatology
UNIVERSITY OF ALABAMA BIRMINGHAM

Natalizumab, Clinical Effects of Alpha-4 Integrin Blockade

Gordon Francis, M.D.
VP, Global Clinical Development
ELAN PHARMACEUTICALS

FEATURED PAPERS ON:

Roflumilast
PI3Kg for Rheumatoid Arthritis
LFA-1 Inhibition
Therapeutic Opportunities in the Prostaglandin Pathway
H4 Receptor Antagonists for Allergy and Inflammation
Src-family Selective Lck Inhibitors
Macrolides: From Antibacterials to Anti-Inflammatories
TLR Novel Drug Targets for Autoimmunity

Venue

Two Albany Street
New Jersey
United States
MORE INFO ON THIS VENUE